Susquehanna International Group, LLP Immuno Gen, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $2.98 Million - $7.15 Million	-238,853 Reduced 24.5%	736,034 $21.8 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $4.8 Million - $6.77 Million	-340,771 Reduced 25.9%	974,887 $15.5 Million
Q2 2023 Aug 11, 2023	BUY	$3.75 - $20.05 $2.46 Million - $13.2 Million	656,842 Added 99.7%	1,315,658 $24.8 Million
Q1 2023 May 16, 2023	BUY	$3.67 - $4.92 $1.23 Million - $1.64 Million	334,180 Added 102.94%	658,816 $2.53 Million
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $1.14 Million - $1.58 Million	-250,003 Reduced 43.51%	324,636 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $1.42 Million - $2.06 Million	318,022 Added 123.93%	574,639 $2.75 Million
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $438,064 - $801,031	-139,068 Reduced 35.15%	256,617 $1.16 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $279,545 - $490,845	-65,621 Reduced 14.23%	395,685 $1.88 Million
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $951,353 - $1.5 Million	200,285 Added 76.73%	461,306 $3.42 Million
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $22,459 - $29,483	4,474 Added 1.74%	261,021 $1.48 Million
Q2 2021 Aug 11, 2021	BUY	$5.79 - $8.6 $639,621 - $950,042	110,470 Added 75.62%	256,547 $1.69 Million
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $671,879 - $1.09 Million	103,366 Added 242.01%	146,077 $1.18 Million
Q4 2020 Feb 16, 2021	SELL	$3.7 - $7.66 $219,768 - $454,981	-59,397 Reduced 58.17%	42,711 $275,000
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $35,455 - $50,254	10,277 Added 11.19%	102,108 $367,000
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $294,849 - $474,245	-88,810 Reduced 49.16%	91,831 $423,000
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $255,705 - $820,188	120,616 Added 200.94%	180,641 $616,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $5.8 $716,814 - $1.85 Million	-318,584 Reduced 84.15%	60,025 $306,000
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $1.07 Million - $1.63 Million	-481,305 Reduced 55.97%	378,609 $916,000
Q2 2019 Aug 16, 2019	BUY	$1.8 - $3.3 $13,717 - $25,149	7,621 Added 0.89%	859,914 $1.87 Million
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $266,697 - $488,944	-148,165 Reduced 14.81%	852,293 $1.85 Million
Q1 2019 May 15, 2019	SELL	$2.41 - $5.91 $180,361 - $442,298	-74,839 Reduced 6.96%	1,000,458 $2.71 Million
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $3.43 Million - $8.45 Million	870,823 Added 425.88%	1,075,297 $5.16 Million
Q2 2018 Aug 14, 2018	BUY	$9.52 - $12.15 $1.78 Million - $2.28 Million	187,265 Added 1088.18%	204,474 $1.99 Million
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $92,928 - $145,760	17,209	17,209 $132,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account